Related Experiment Video
Updated: Apr 26, 2026
06:49
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
Published on: October 6, 2015
19.7K
Standardized, systemic phenotypic analysis of Slc12a1I299F mutant mice.
Journal of Biomedical Science
|August 3, 2014
Summary
Mutations in the SLC12A1 gene cause Type I Bartter syndrome, affecting kidney function. A mouse model revealed additional phenotypes like lower body weight and fat content, suggesting broader systemic effects beyond the kidneys.
Area of Science:
- Nephrology
- Genetics
- Physiology
Background:
- Type I Bartter syndrome is a genetic kidney disease caused by mutations in the SLC12A1 gene, affecting the NKCC2 cotransporter.
- A mouse model (Slc12a1I299F) mimics human disease phenotypes, including kidney defects, low blood pressure, and osteopenia.
- NKCC2 is expressed not only in the kidneys but also in the gastrointestinal tract, pancreatic beta cells, ear, nasal tissue, and eye.
Purpose of the Study:
- To conduct a systemic phenotypic analysis of the Slc12a1I299F mutant mouse line.
- To investigate potential primary or secondary effects of the Slc12a1I299F mutation on organ systems and metabolic pathways beyond the kidneys.
Main Methods:
- Standardized phenotypic analysis of Slc12a1I299F homozygous mutant mice and heterozygous littermate controls.
- Testing was performed at 4-6 months of age at the German Mouse Clinic.
Main Results:
- Homozygous mutant mice exhibited significantly lower body weight and fat content compared to controls.
- Mild erythropenic anemia was observed in males, and slight hyperalgesia in females.
- No distinct alterations were found in immunology, lung function, or neurology.
Conclusions:
- The Slc12a1I299F mutation did not show clear primary effects in organs other than the kidneys.
- Long-term effects secondary to kidney lesions may occur in humans with SLC12A1 mutations.
